Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 2
Submit an article Journal homepage
73
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Production of Proangiogenic Cytokines During Thalidomide Treatment of Multiple Myeloma

Anna Dmoszyńska Department of Haematology, University School of Medicine, Jaczewskiego 8, 20-950, Lublin, Poland
,
Agnieszka Bojarska-Junak Department of Clinical Immunology, University School of Medicine, Jaczewskiego 8, 20-950 Lublin, Poland
,
Damian Domański Department of Clinical Immunology, University School of Medicine, Jaczewskiego 8, 20-950 Lublin, Poland
,
Jacek Roliński Department of Clinical Immunology, University School of Medicine, Jaczewskiego 8, 20-950 Lublin, Poland
,
Marek Hus Department of Haematology, University School of Medicine, Jaczewskiego 8, 20-950, Lublin, Poland
&
Maria Soroka-Wojtaszko Department of Haematology, University School of Medicine, Jaczewskiego 8, 20-950, Lublin, Poland
Pages 401-406 | Published online: 01 Jul 2009

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Archana Bhaskar, Ritu Gupta, Sreenivas Vishnubhatla, Lalit Kumar, Atul Sharma, Mehar Chand Sharma, Prasenjit Das & Sonu Chand Thakur. (2013) Angiopoietins as biomarker of disease activity and response to therapy in multiple myeloma. Leukemia & Lymphoma 54:7, pages 1473-1478.
Read now
Konstantinos Anargyrou, Meletios-Athanassios Dimopoulos, Orhan Sezer & Evangelos Terpos. (2008) Novel anti-myeloma agents and angiogenesis. Leukemia & Lymphoma 49:4, pages 677-689.
Read now
Tsuyoshi Iwasaki & Hajime Sano. (2003) Predicting Treatment Responses and Disease Progression in Myeloma using Serum Vascular Endothelial Growth Factor and Hepatocyte Growth Factor Levels. Leukemia & Lymphoma 44:8, pages 1347-1351.
Read now
Tsuyoshi Iwasaki & Hajime Sano. (2003) Predicting Treatment Responses and Disease Progression in Myeloma using Serum Vascular Endothelial Growth Factor and Hepatocyte Growth Factor Levels. Leukemia & Lymphoma 44:8, pages 1275-1279.
Read now
V. Eleutherakis-Papaiakovou, M. Karali, I. Kokkonouzis, I. Tiliakos & M.A. Dimopoulos. (2003) Bone Marrow Angiogenesis and Progression in Multiple Myeloma: Clinical Significance and Therapeutic Approach. Leukemia & Lymphoma 44:6, pages 937-948.
Read now

Articles from other publishers (18)

Anastasios Tentolouris, Ioannis Ntanasis-Stathopoulos & Evangelos Terpos. (2023) Obesity and multiple myeloma: Emerging mechanisms and perspectives. Seminars in Cancer Biology 92, pages 45-60.
Crossref
Priyanka S. Rana, Krishna Goparaju & James J. Driscoll. (2023) Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma. Frontiers in Oncology 13.
Crossref
Dominika Bębnowska, Rafał Hrynkiewicz, Ewelina Grywalska, Marcin Pasiarski, Barbara Sosnowska-Pasiarska, Iwona Smarz-Widelska, Stanisław Góźdź, Jacek Roliński & Paulina Niedźwiedzka-Rystwej. (2021) Immunological Prognostic Factors in Multiple Myeloma. International Journal of Molecular Sciences 22:7, pages 3587.
Crossref
Marta Irigoyen, Juan Carlos García-Ruiz & Edurne Berra. (2017) The hypoxia signalling pathway in haematological malignancies. Oncotarget 8:22, pages 36832-36844.
Crossref
Marta Robak, Jacek Treliński & Krzysztof Chojnowski. (2012) Hemostatic changes after 1 month of thalidomide and dexamethasone therapy in patients with multiple myeloma. Medical Oncology 29:5, pages 3574-3580.
Crossref
Jean A. Hurteau, Mark F. Brady, Kathleen M. Darcy, William P. McGuire, Pamela Edmonds, Michael L. Pearl, Iouri Ivanov, Krishnansu S. Tewari, Robert S. Mannel, Kristine Zanotti & Doris M. Benbrook. (2010) Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study. Gynecologic Oncology 119:3, pages 444-450.
Crossref
K Giannopoulos, A Dmoszynska, M Kowal, E Wąsik-Szczepanek, A Bojarska-Junak, J Rolinski, H Döhner, S Stilgenbauer & L Bullinger. (2009) Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia. Leukemia 23:10, pages 1771-1778.
Crossref
D. Scott McMeekin, Michael W. Sill, Kathleen M. Darcy, Deborah J. Stearns-Kurosawa, Kenneth Webster, Steven Waggoner & Doris Benbrook. (2007) A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: A gynecologic oncology group study. Gynecologic Oncology 106:3, pages 596-603.
Crossref
Krzysztof Giannopoulos, Anna Dmoszyńska & Jacek Roliński. (2007) Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pretreated patients with chronic lymphocytic leukemia. Leukemia Research 31:3, pages 411-412.
Crossref
Mitchell S. Anscher, Jennifer Garst, Lawrence B. Marks, Nicole Larrier, Frank Dunphy, James E. HerndonIIII, Robert Clough, Christine Marino, Zeljko Vujaskovic, Sumin Zhou, Mark W. Dewhirst, Timothy D. Shafman & Jeffrey Crawford. (2006) Assessing the ability of the antiangiogenic and anticytokine agent thalidomide to modulate radiation-induced lung injury. International Journal of Radiation Oncology*Biology*Physics 66:2, pages 477-482.
Crossref
Christian Jakob, Jan Sterz, Ivana Zavrski, Ulrike Heider, Lorenz Kleeberg, Claudia Fleissner, Martin Kaiser & Orhan Sezer. (2006) Angiogenesis in multiple myeloma. European Journal of Cancer 42:11, pages 1581-1590.
Crossref
R.E. Kast. (2005) Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: New insights into the biology of TNF-alpha giving new treatment opportunities-the role of bupropion. Leukemia Research 29:12, pages 1459-1463.
Crossref
Takeshi YabuHidekazu TomimotoYoshimitsu TaguchiShohei YamaokaYasuyuki IgarashiToshiro Okazaki. (2005) Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. Blood 106:1, pages 125-134.
Crossref
Chiun Hsu, Chiung-Nien Chen, Li-Tzong Chen, Chen-Yao Wu, Fon-Jou Hsieh & Ann-Lii Cheng. (2005) Effect of Thalidomide in Hepatocellular Carcinoma: Assessment with Power Doppler US and Analysis of Circulating Angiogenic Factors. Radiology 235:2, pages 509-516.
Crossref
I Hus, A Dmoszynska, J Manko, M Hus, D Jawniak, M Soroka-Wojtaszko, A Hellmann, H Ciepluch, A Skotnicki, T Wolska-Smolen, K Sulek, T Robak, L Konopka & J Kloczko. (2004) An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma. British Journal of Cancer 91:11, pages 1873-1879.
Crossref
Judith H. HarmeyPhilip T. Murphy & John Quinn. 2004. VEGF and Cancer. VEGF and Cancer 83 106 .
J N Gordon & P M Goggin. (2003) Thalidomide and its derivatives: emerging from the wilderness. Postgraduate Medical Journal 79:929, pages 127-132.
Crossref
S.James Matthews & Christopher McCoy. (2003) Thalidomide: A review of approved and investigational uses. Clinical Therapeutics 25:2, pages 342-395.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.